All lobbying filings

THORNROSE VENTURES

THORNROSE VENTURES filed a registration for MEDSIGN INTERNATIONAL CORPORATION on September 8, 2026.

Lobbying for MEDSIGN INTERNATIONAL CORPORATION · MedSign International Corporation operates as a specialized healthcare technology.

All filings by THORNROSE VENTURES · Everything MEDSIGN INTERNATIONAL CORPORATION has reported

Filing · LD-1 registration Registration

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Sep 8, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

Florida

Official filing document

Lobbyists on this filing 1

JOHN MASON LONG New on this filing

Previously held: US Department of Health & Human Services, Special Assistant office of Intergovernmental and External Affairs

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Lobbying activity 6

Aviation/Airlines/Airports

Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.

Budget/Appropriations

Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.

Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.

Computer Industry

Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.

Government Issues

Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.

Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem